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Abstract: Endogenous retroviruses (ERVs) in mammals are closely related to infectious retroviruses
and utilize host tRNAs as a primer for reverse transcription and replication, a hallmark of long terminal
repeat (LTR) retroelements. Their dependency on tRNA makes these elements vulnerable to targeting
by small RNAs derived from the 3′-end of mature tRNAs (3′-tRFs), which are highly expressed during
epigenetic reprogramming and potentially protect many tissues in eukaryotes. Here, we review some
key functions of ERV reprogramming during mouse and human development and discuss how
small RNA-mediated silencing maintains genome stability when ERVs are temporarily released from
heterochromatin repression. In particular, we take a closer look at the tRNA primer binding sites
(PBS) of two highly active ERV families in mice and their sequence variation that is shaped by the
conflict of successful tRNA priming for replication versus evasion of silencing by 3′-tRFs.
Keywords: endogenous retrovirus (ERV); tRNA-fragment (tRF); small RNA silencing; tRNA primer
binding site (PBS); RNA interference (RNAi); intracisternal A-particle (IAP); early transposon (ETn);
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1. Introduction
Reverse transcription and long terminal repeat (LTR) retroelements are ancient components
of eukaryotic genomes [1]. In fact, reverse transcriptase (RT) is one of the most abundant genes
in organisms with high copy numbers of retroelements such as mammals [1–3]. LTR-retroviruses
encode envelope proteins to form virus particles and infect neighboring cells or other organisms,
while LTR-retrotransposons that lack functional envelope proteins replicate within viral-like particles
(VLPs) to integrate into the same cell. The majority of LTR-retrotransposons in mammals are closely
related to known infectious LTR-retroviruses and are therefore called endogenous retroviruses (ERVs).
Based on the phylogenetic relationship of their RT genes, mammalian ERVs belong to the Retroviridae
genus, while LTR-retrotransposons prevalent in other phyla such as the Gypsy and Copia superfamilies
are Metaviridae and Pseudoviridae, respectively [4–6]. All three genera include infectious, viral elements
with an envelope gene as well as endogenous transposons that proliferate in a strictly intracellular
fashion. Endogenous LTR-retrotransposons that lost a functional envelope gene are inherited vertically
but may in principle, at low frequency, spread to other organisms by horizontal transfer, a process
used by all transposable elements to enter new host species [7,8]. ERVs have become resident
aliens in mammalian genomes and many of them were co-opted by their hosts to fulfill essential
cellular functions, for example, during placentation and imprinting [9–11]. ERV promoter and
enhancer activities as well as their protein domains have been useful building blocks during evolution,
while their repetitive ends induce recombination and mobility of intact, full-length elements is highly
mutagenic [12–17]. Hence, their expression needs to be carefully monitored by the cell. This review
will discuss how small RNAs identify and silence ERVs when they are released from heterochromatin
during epigenetic reprogramming.
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With few exceptions, LTR-retroelements use host tRNA to prime reverse transcription and copy
their RNA into DNA for insertion into the genome (Figure 1) [18–21]. tRNAs are essential host
molecules that are abundantly available at the point that viral proteins are translated. Retroviral
proteins bind specific tRNAs with high affinity and recruit them to the virus particle or VLP where
their 3′-end initiates reverse transcription at the tRNA primer binding site (PBS). Small RNAs derived
from the 3′-end of tRNAs (3′-tRFs) target LTR-retroelements at the PBS and control their mobility and
expression [22–24]. These highly conserved sequence motifs are a prerequisite for replication and
allow host defense mechanisms to identify active LTR-retroelements. ERV sequences make up ~10% of
the mouse and human genome, but only a few full-length copies are capable of retrotransposition.
Variations of the PBS sequences amongst two highly active ERV families hint at what may be the perfect




























Figure 1. Model of reverse transcription of long terminal repeat (LTR)-retrotransposons and -viruses.
LTRs encode promoter elements and termination signals. The RNA transcript contains a region repeated
at either end (R), a 5′ unique segment (U5), and a segment only included at the 3′-end of the RNA
(U3). The 3′-end of cellular tRNAs (blue cloverleaf) primes reverse transcription by hybridizing to the
primer binding site (PBS). While this segment is being copied into first-strand cDNA (light blue line),
also called minus (−) strong stop DNA, the RNaseH activity of reverse transcriptase (RT) degrades
the template RNA. The elongating cDNA is transferred to the 3′-end of the retrotransposon transcript
hybridizing to the R region. The remaining RNA is partially degraded by RNaseH leaving behind
primers for second-strand, plus (+) cDNA synthesis. In Retroviridae, the plus strand PBS is a copy of the
tRNA primer, while the minus strand is a copy of the original PBS sequence. After another transfer
event, first (−) and second (+) strand synthesis are completed to result in a full-length, double-stranded
retroviral DNA that will be integrated into the host genome.
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2. Epigenetic Reprogramming of ERVs
2.1. De-repression of ERVs during Chromatin Reprogramming
ERVs are usually embedded in repressive heterochromatin, but importantly become active during
epigenetic reprogramming in development and disease. Mammals undergo genome-wide epigenetic
reprogramming in the embryo right after fertilization and in the germline to obtain totipotency and
set aside cells for the next generation [25–27]. ERV transcription is repressed by DNA and histone
methylation. The histone methyltransferases G9a/GLP, SETDB1, EZH2, histone demethylase KDM1A,
as well as the de novo DNA methyltransferases DNMT3a/b, DNMT3L, and DNMT3C establish
heterochromatin at different classes of ERVs as discussed in detail elsewhere [28,29]. DNA methylation
status can directly correlate with ERV transcription [29–33]. However, absence of DNA methylation
does not necessarily lead to ERV expression, as long as histone H3 lysine K9 tri-methylation (H3K9me3)
can be maintained [34–37]. The histone H3K9me3 methyltransferase SETDB1 is acting in complex
with KAP1/TRIM28 on fully methylated or fully unmethylated DNA, but not hemi-methylated DNA
that is occupied by NP95 [37]. This finding resolves why ERV expression is not always observed
in stable methylation knock-outs but is observed in inducible knock-outs that undergo temporary
hemi-methylation, and most importantly during epigenetic reprogramming in vivo which includes
a hemi-methylated state [32,33,37]. Like any gene, transposon expression depends on multiple
layers of repressive and permissive control on the RNA, DNA, and protein level. Removal of
silent chromatin marks allows transcription factors (TFs) to bind DNA and promote or inhibit ERV
transcription [38–40]. LTR sequences, for example, contain species-specific TF binding sites that
promote temporary expression of ERVs and neighboring genomic sequences during development [38].
After reprogramming, chromatin patterns at transposable elements need to be re-established through
DNA and RNA recognition. KRAB zinc finger proteins (ZFPs) have co-evolved with their transposon
targets and guide heterochromatin formation by SETDB1, TRIM28/KAP1 through binding to highly
conserved DNA sequence motifs in ERVs [41]. For example, some KRAB-ZFPs bind to the PBS
of select ERVs or the polypurine tract that primes second strand reverse transcription during ERV
replication [42]. Once transcribed, ERV expression, translation, and reverse transcription must be
restricted by the cell, and small RNAs have the ability to recognize and target transposon RNA
for silencing.
2.2. ERVs as Epigenetic Switches in Development and Disease
The propensity of ERVs to attract diverse silencing machineries that act upon specific transposon
families at different stages of development make them ideal epigenetic switches [17]. An estimated
6–30% of transcripts in mouse and human embryonic and somatic tissues are driven by retrotransposon
promoters in a highly tissue-specific manner [43]. ERV families define gene-regulatory networks
throughout development [12,13]. Transcription of murine MERV-L elements marks the totipotent
two-cell stage in early embryos [44]. Human HERV-H expression is indicative of the naive embryonic
stem cell state and essential for pluripotency [45,46]. In addition, ERV LTR promoter-enhancer
activity drives non-coding, stem-cell specific transcripts that maintain the undifferentiated state
and are crucial for cell identity [47–50]. More than 800 LTRs from the ERV-L and mammalian
apparent LTR-retrotransposon (MaLR) families act as alternative promoters and first exons to drive
stage-specific gene expression in mammalian oocytes and the developing zygote [25,51]. Taken together,
temporary release of transposon silencing during reprogramming affects the transcriptome through
(i) expression of potentially mobile, mutagenic, intact transposons, (ii) expression of transposon-derived,
long non-coding regulatory RNAs (lncRNAs), and (iii) expression of neighboring genes or lncRNAs
driven by promoter-enhancer activities of the LTRs.
The epigenetic state of ERVs and transposable elements in general can not only lead to
developmental stage- and cell-type-specific expression but also establish epigenetic alleles or “epialleles”
that result in differential expression between isogenic offspring [52,53]. Epialleles can be stable and
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inherited if they entirely escape reprogramming or “metastable” and lead to stochastic changes of
the epigenetic state in the offspring [53]. The most famous example of an ERV-induced metastable
epiallele is the differential methylation of an intracisternal A-particle (IAP) insertion upstream
the mouse Agouti gene which results in varying fur color and obesity in siblings [30]. In fact,
such metastable epialleles of IAP are extremely abundant genome-wide, but few of them affect
neighboring gene expression [31]. Select ERVs, particularly a set of IAP elements, are protected from
reprogramming in the early embryo and the germline, and therefore inherit their epigenetic state as
stable epialleles [54,55]. Human ERV (HERV) methylation varies between individuals that could be
metastable epialleles, but it is hard to exclude genetic variation [53,56]. Notably, many imprinted genes
are derived from LTR-retrotransposons. Imprinted genes of the sushi-ichi-related retrotransposon
homologs (SIRH) are common to placental mammals and derived from Metaviridae gypsy-elements [57].
Lineage-specific Retroviridae ERV insertions mediate imprint establishment at murine loci such as
retrotransposon-like 1 (Rtl1), Rasgrf1, Impact, and Slc38a4 [58–60]. The murine ERVK family drives
non-canonical, histone-dependent imprinting in the extraembryonic lineage [61]. Imprinted loci are
established during epigenetic reprogramming of the germline and persist in the early embryo [54,62,63].
In contrast to epialleles, heterochromatin induction at imprinted loci is not stochastic but established at
either the paternal or maternal allele, respectively, and is essential for proper development.
Similar to epigenetic reprogramming in development, ERV reactivation has been observed in
other tissues with high epigenetic plasticity, particularly in the course of disease [17,64,65]. The role
of ERVs in cancer extends beyond their value as diagnostic markers for aberrant reprogramming.
They are frequently epigenetically reactivated as cryptic promoters in cancer and drive oncogene
expression [47,66–68]. Indeed, LTR-retroviruses were originally identified as the causative agents of
transmissible tumors in chicken, mice, and humans [69]. Those ‘RNA tumor viruses’ include Rous
sarcoma virus (RSV), mouse mammary tumor virus (MMTV), and human T cell leukemia virus
1 (HTLV-1). However, expression of endogenous HERV proteins can also tip the scales and trigger
an immune response that drives tumor cells into apoptosis [70].
3. Small RNA Silencing of ERVs
3.1. Small RNAs during Reprogramming in the Mammalian Embryo
When transposable elements are released from repressive chromatin during epigenetic
reprogramming in development and disease, small RNA-mediated silencing mechanisms become
crucial to limit transposition and maintain genome integrity [71–73]. Argonaute (AGO) and P-element
induced wimpy testis (PIWI) proteins are the core of the RNA interference (RNAi) machinery
and bind small RNAs to mediate silencing of complementary sequences. Genome-wide epigenetic
reprogramming in mammals invokes transposon expression in the zygote right after fertilization and
in developing germ cells which determine transposon burden of the next generation [25–27]. By far the
most is known about PIWI-interacting RNAs (piRNAs) silencing ERVs in the male germline and there
are many excellent reviews on the topic [72–74]. Pre-pachytene stage piRNAs in primordial germ cells
of mice are highly enriched in transposon sequences and inhibit ERVs post-transcriptionally through
mRNA binding as well as transcriptionally by guiding de novo methylation [75–77]. Transcriptional
silencing guided by small RNAs is well established in other eukaryotes, yet, how PIWI proteins recruit
the chromatin machinery to transposon sequences in mice remains elusive [73,78]. Small RNA-mediated
silencing does not only prevent mutagenic damage from transposition, but importantly regulates
repetitive elements that have been co-opted by the host to serve essential functions. For example,
silencing of the paternally imprinted Rasgrf1 locus in mouse is mediated by piRNAs that target an ERV
sequence [60].
In the female germline of Muridae, endogenous small interfering RNAs (endo-siRNAs) target
transposon mRNA and protect oocytes [26,79–81]. An oocyte-specific isoform of the endonuclease
DICER is produced due to temporary reactivation of an intronic ERV and processes endo-siRNAs
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from long double-stranded RNAs which invoke an interferon immune-response in most other cell
types of mammals [82]. Human oocytes express a PIWI gene that is lacking in several rodents and
produce “oocyte short piRNAs” that target HERVs [83]. However, deletion of DICER and PIWI
proteins results in chromosomal defects that cannot be explained by control of active transposition
alone but point to a role of the RNAi machinery more broadly in repeat and genome stability [84].
Hundreds of DICER-dependent miRNAs originate from and theoretically target ERV sequences in
mice and humans [85–87]. A functional relationship has yet been shown for one miRNA that regulates
the Rtl1 imprinted gene in mouse placenta [59]. MiRNAs target and sense LTR-retroelements in plant
development [88,89] and regulate non-LTR retroelements such as long interspersed nuclear element
(LINE)-1 in human [90,91]. However, the impact of miRNAs on genome-wide ERV reactivation in
mammals is unclear.
Small RNAs expressed in the germline are well-known to restrict transposable elements, but it is
less clear how transposition is avoided during the first wave of reprogramming that enables totipotency
in the pre-implantation embryo. DICER-dependent silencing of IAP and MERV-L transcripts was
detected up to the eight-cell stage in mouse embryos [92]. However, siRNAs and piRNAs abundant in
gametes are depleted at later stages of pre-implantation with minimal heterochromatin and absent
in other somatic tissues that reactivate transposable elements in mouse and human [26,79–81,93].
ERVs are strongly expressed in the absence of H3K9me3 in mouse embryonic stem cells (mESCs) and
preimplantation embryos [25,35,94]. Indeed, one of the most mutagenic transposon families in mouse
was coined “Early Transposon” (ETn) because of its strong expression in early embryogenesis [95].
Small RNAs derived from the 3′-end of mature tRNAs (3′-tRFs) are expressed in stem cells and
tissues of pre-implantation mouse embryos as well as cancer cells with high ERV burden and strongly
inhibit retrotransposition (our unpublished results and [22]). 3′-tRFs include the post-transcriptional
trinucleotide CCA-tail of mature tRNAs and consequently do not match genomic tDNA sequences
but perfectly match LTR-retroelements at their highly conserved PBS. Hence, 3′-tRFs recognize any
potentially mobile ERV that is able to bind host tRNA for replication, thus distinguishing harmful from
harmless copies amongst large numbers of ERV-derived sequences [20].
3.2. tRNA Fragments and RNA Interference
tRFs are a novel class of small non-coding, regulatory RNAs with distinct types, length, and diverse
biological functions: 3′-tRFs and 5′-tRFs that are not the reverse complement of each other, stress-induced
tRNA halves, internal fragments, and tRFs of precursor tRNAs [20,96]. Several tRF types bind to
AGO and PIWI proteins in multiple organisms [23,24,97–103], and can guide silencing of reporter
constructs with complementary binding sites in their 3′ untranslated region (UTR) [98,102,104]. In fact,
some previously annotated miRNAs turn out to be tRFs [101,105–107]. Recently, biological targets of
3′-tRFs were uncovered and post-transcriptional gene silencing was confirmed [22,101]. Due to their
perfect sequence complementarity to the PBS of LTR-retroelements, 3′-tRFs have tens of thousands
of ERV targets in mammalian genomes. 3′-tRFs come in two distinct sizes that are expressed in cell
type specific ratios: 17–19 nucleotides (nt) long tRF3a fragments specifically interfere with reverse
transcription, while 22 nt tRF3b fragments inhibit coding-competent ERVs with all the hallmarks of
miRNA silencing [22]. Indeed, a glycine tRF3b fragment has been shown to act as an AGO2-dependent
miRNA in vivo targeting an essential, human replication protein [101]. tRF3b fragments that target
the PBS in the 5′-UTR of ERVs decrease RNA and protein levels [22]. Interestingly, the majority of
3′-tRFs bound to endogenous AGO2 in human cells are the shorter tRF3a fragments [103], which are
also the major, functional cargo of the Tetrahymena PIWI protein Twi12 [99], suggesting 3′-tRFs are
highly conserved substrates of the RNAi silencing machinery. tRNAs are thought to have evolved
from minihelices including the entire portion of 3′-tRFs and a few nucleotides of the ‘modern day’
double helix 5′-end [108]. Minihelices are functional substrates for the CCA-adding enzyme during
tRNA maturation [109], and specific nucleotides in the acceptor stem portion of the minihelix are
necessary and sufficient for aminoacylation, supporting the idea of a primordial code by tRNA
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minihelices [108,110]. The L-shaped tertiary structure of tRNA resembles other double-stranded RNA
substrates of RNAi. The presence of 3′-tRFs in AGO/PIWI pulldowns, despite large amounts of miRNAs
or piRNAs in some of those cell types, argues that they are functional substrates and direct the RNAi
machinery to transposon targets [20].
Given the variable expression of ERVs throughout development and even between genetically
identical individuals, small RNAs arguably serve well to sense and adjust ERV expression. Small RNA
mediated host defense often scales with transposable element burden and acts at different levels:
piRNAs in mammals are produced from single-stranded precursor RNA of clusters of transposon
sequences already in the host genome, and siRNAs are produced from double-stranded RNA of
transposon transcripts [73,82,111,112]. 3′-tRFs can be seen as an innate immune response— they readily
exist in all organisms without prior exposure to that particular LTR-retroelement and specifically
recognize any potentially mobile copy by the presence of its conserved PBS. In this sense, the PBS
is the Achilles’ heel of retrotransposition: if this sequence is mutated, the transposon evades tRF
silencing but also loses its ability to replicate using host tRNAs. tRF targeting is likely a highly
conserved mechanism of small RNA-mediated transposon control. While many small RNAs also
target mRNA of domesticated transposon domains, 3′-tRFs enable the host to discriminate self from
non-self: transposon-derived coding sequences with no PBS go incognito, while mobile elements and
active retroviruses require an intact PBS sequence, with complementarity to 3′-tRFs.
4. Two Highly Active ERV Families in Mouse and Their Primer Binding Site Variations
4.1. Replication of ERVs and other Retroviridae
Genome sequencing projects have given insight into the spread of repetitive elements over
evolutionary time and into which transposons cause polymorphisms when comparing strains or
individuals. In mice, ERVs are highly active causing an estimated 10% of germline mutations in today’s
inbred laboratory strains [14,113]. The ERV superfamilies IAP (Gammaretroviridae) and ETn/MusD
(Betaretroviridae) are among the most active transposons in mouse with the majority of novel insertions
being non-autonomous copies carried over by a few coding family members [14,114,115]. ETn elements
are non-autonomous and depend on the enzymatic machinery of autonomous MusD elements related
by identical LTR sequences and usage of the same primer tRNA. Autonomous ERVs contain at least three
open reading frames and undergo mRNA splicing and translation to produce the group-specific-antigen
(Gag) polyprotein that assembles the VLP, protease (Pr) for maturation of the gene products, and reverse
transcriptase (RT) [20,116]. Two copies of unspliced viral template RNA are recruited directly into
the VLP for reverse transcription. Non-autonomous elements are non-coding and hitchhike on the
enzymatic machinery provided by the autonomous family member. Their genomic RNA does not
undergo splicing or translation but is directly transported into the VLP. From studies of murine leukemia
virus (MLV), human immunodeficiency virus (HIV), and RSV, we have an idea about RNA content and
stoichiometries in the VLP or virus particle [117,118]. The majority of RNA molecules are tRNAs with
estimates ranging from 70–700 tRNAs per particle. Interestingly, other co-packed RNAs (i.e., 7SL RNA,
Y RNAs, U6 snRNAs), although not abundant, are transcripts generated by polymerase III (POLIII),
just like tRNAs, suggesting an intersection of POLIII-regulated transcripts with retroelement evolution.
Non-LTR retroelements are thought to be evolutionarily older and likewise interact with POLIII
transcripts: human LINEs frequently pick up U6 RNA during retrotransposition [119] and have reverse
transcribed 7SL RNA to generate Alu elements in Xenopus, Drosophila, and human [120].
The most highly enriched molecules in viral particles or VLPs are the tRNA primer isotype used
for reverse transcription, for example, lysine for HIV-1, representing 70% of all packaged tRNAs [118].
IAP elements use phenylalanine tRNA (coding the GAA triplet) to prime reverse transcription and are
inhibited by 3′-fragments of those same tRNAs (3′-tRFPhe-GAA) [22]. ETn/MusD elements use the same
primer as HIV, tRNALys-UUU, and are targeted by 3′-tRFLys-UUU [22,24]. tRNAs with a specific codon
can include different isodecoders with variable sequences, indicated by numbers in addition to the
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codon triplet letters [110,121], so more precisely ETn/MusD and HIV are primed by tRNA Lysine3-UUU
and inhibitory 3′-tRFs are derived from this exact sequence. HIV and MLV only use cytoplasmic
tRNAs that have passed rigorous quality control by the cell and are capable of being charged with the
correct amino acid [122]. Primer tRNAs are enriched in viral particles by RT in several Retroviridae such
as HIV, RSV, MLV, and avian sarcoma leukosis virus (ASLV) [123]. In the case of HIV, Gag-Pol proteins
recruit the Lysine3-UUU tRNA primer through interaction with Lysyl-tRNA synthetase and prevent
aminoacylation of the tRNA [124]. Some Retroviridae like RSV follow this route, while others like
MLV do not package tRNA synthetases [123,124]. In general, RT enzymes evolved to bind specific
tRNAs with high affinity to initiate reverse transcription. tRNA priming requires more than an 18 nt
match at the PBS and tRNA annealing in HIV-1 is concomitant with a series of conformational
changes of the retrovirus RNA during VLP formation [125]. Although short oligonucleotides prime
reverse transcription of heat-denatured templates in vitro, priming and elongation in vivo require the
interaction of the RT enzyme with the full-length, structured tRNA and mutations at critical residues
outside the 3′-acceptor arm impair processivity [18,126]. This results in a de facto suppression of
reverse transcription in vivo when tRNAs and tRFs compete [22,24].
4.2. Measuring LTR-Retrotransposon Activity
There are a number of techniques to quantify active retrotransposition and probe its regulation.
RNA levels are often used as a proxy for transposon activity, but transcription is only one step in the
life cycle of transposons and does not necessarily reflect mobility and mutagenic burden, for example,
if transposition is inhibited post-transcriptionally by small RNAs. LTR-retrotransposon activity can be
experimentally assessed almost every step of the way. Capped, spliced RNA levels reflect mRNA before
translation [43,48,127], while unspliced full-length transcripts are the viral “genomic” RNA template
for reverse transcription. RNaseH intermediates of strong stop, first strand cDNA can be detected
by 5′-RACE of uncapped RNA ends using transposon-specific primers [22]. Extrachromosomal viral
DNA copies can be separated from genomic host DNA by a simple alkaline-lysis. Viral particles
and VLPs have been purified to sequence packaged RNA or retroviral DNA of reverse transcription
intermediates [117,128]. These DNA intermediates can be functional and subsequently integrate but
also reveal aberrant products of transposons that lack the ability to integrate. Extrachromosomal
cDNA of LTR-retroelements that persists as episomal circular DNA is generally considered a dead-end
abrogation product but can be actively transcribed and contribute to the viral protein load in the
cell [129]. Ultimately, retrotransposition assays with reporter gene cassettes allow to quantify successful
integration and to trace intermediates of a specific element [130]. Transposition assays are typically
performed in a naive host such as in human cells for murine ERVs, because the original host contains
multiple layers of defense mechanisms and thousands of untagged, related transposon copies that
may be co-mobilized and confound quantification.
Retrotransposition assays with an autonomous and a non-autonomous element allow to dissect
the effect of PBS mutations and endogenous 3′-tRFs on ERV activity. A coding-competent MusD
element with a scrambled PBS can no longer prime its own reverse transcription but can still replicate its
non-autonomous partner, ETn [22]. Without a functional PBS, MusD escapes targeting by tRFs resulting
in increased expression of its enzymatic machinery that mediates increased retrotransposition of ETn.
Disruption of the PBS of the non-autonomous ETn simply results in a “dead” copy. Hence, coding
elements with mutations that prevent tRF silencing and mobility can be potent sources of viral protein
production and be able to retrotranspose non-coding elements, as long as the latter retain a functional
PBS. That applies to elements such as MusD that are able to efficiently mobilize non-autonomous copies
in trans, and perhaps explains the much higher copy numbers for ETn over MusD in murine genomes.
ERVs with cis-preference, such as IAP elements, bind and retrotranspose their own RNA in cis, at much
higher frequencies than RNA from other elements [131]. For such retroelements, disruption of tRNA
priming should immediately penalize retrotransposition. Retrotransposition assays, Gag protein and
mRNA detection, together with ERV-specific 5′-RACE of uncapped retroviral RNA intermediates
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have revealed mechanisms of tRF inhibition: tRF3a fragments decrease RNaseH cleavage products
around the PBS, an indicator of successful priming and processivity by RT, while tRF3b fragments
reduce mRNA and protein levels similar to miRNAs [22]. Therefore, autonomous elements are strongly
affected by both types of tRFs, while non-coding elements are regulated by tRF3a fragments only at the
RT step.
4.3. A Trade-Off between Priming and Silencing?
One would expect a trade-off between a perfect PBS for tRNA priming but susceptibility to tRF
silencing. PBS sequences that allow tRNA priming but reduce tRF silencing would be most “successful”
and accumulate in the pool of full-length ERVs. We collected the PBS sequences of four ERV families,
whose activity has been tested in retrotransposition assays, and compared them for mismatches
with the perfect PBS (Figure 2). Over time, ERVs accumulate random mutations just like any other
sequence in the genome. ERVs that acquire beneficial mutations should proliferate more and dominate
the sequences we find in the genome, while deleterious mutations will halt copy number increase.
Strikingly, the most common PBS sequences for the examined ETn, MusD, and IAP families have
mismatches with the tRNA primer and have mutations compared to a “perfect” PBS. This strongly
suggests that mutations in the PBS indeed confer an advantage for the ERV, most likely because they
reduce silencing by tRFs. These mutations still allow tRNA priming and replication, as elements with
the most common PBS were active in retrotransposition assays (see Figure 2) [114,115,131,132]. We drew
phylogenetic trees of the full-length ETn and MusD sequences to estimate whether these mutations
occurred in one highly active ERV that produced high copy numbers or whether these permissive
mutations got fixed in independent events (Figures S1 and S2). The phylogenetic trees of both, ETn and
MusD, show perfect (0 mismatch with tRNA primer) and most common (two mismatches) PBS
sequences across the entire tree, not from a single clade, indicating repeated, independent mutation
events and specific mutations allowing higher copy numbers. Among highly related ERVs, such as
in the top right corner of the ETn cladogram, some seem to have “reverted” from the common
PBS to a perfect one (Figures S1 and S2). We would like to speculate that this is due to the tRNA
primer sequence being copied and inherited with a 50:50 chance, similar to PBS propagation in other
Retroviridae. The Retroviridae HIV and Moloney MLV copy the primer tRNA sequence during second
strand synthesis and therefore produce dsDNA and insertions that carry their parent PBS on one
strand and the tRNA copy on the other strand (Figure 1) [133,134]. In contrast, the Pseudoviridae
copia transposon yeast 1 (Ty1) and Metaviridae gypsy Ty3 elements copy the PBS during reverse
transcription to both strands and therefore strictly inherit their PBS sequence [135]. The PBS alignments
and phylogenetic analysis of the ETnIIbeta family also revealed that ETn can switch to use a Lys1,2-CUU
tRNA as a primer (Figure 2b and Figure S1). Indeed, a known active ETnI1 element carries a Lysine1,2
signature and its PBS sequence was added to the ETnIIbeta alignment for comparison (Figure 2b).
Similarly, rare HIV-1 copies have been isolated that use an alternative Lysine primer [136], and MLV
which usually uses tRNAPro1,2 can adapt to use tRNAGln-GUC [137].
Of note, the majority of PBS mutations are found at certain positions (Figure 2, shaded in black).
These could be mutations permissive or beneficial to retrotransposition or, alternatively, mutational hot
spots during reverse transcription and DNA maintenance. DNA methylation at CpG residues often
leads to mutations. These manifest as C to A and T to G changes across two adjacent bases because the
cytosine of the reciprocal strand is as likely to mutate. The PBS sequences analyzed here do not follow
this pattern. In addition, the most common mutations in the PBS have not accumulated so much over
time but are more frequent in younger ERV copies with high percent identity between their left and
right LTR (Figures S1 and S2). G to A and C to T mutations have been found in HIV-1 and are attributed
to limited dCTP concentrations during reverse transcription or RNA editing of viral DNA [139].
We spot some C to T mutations, but the majority of PBS mutations cannot be explained by this
mechanism. RT enzymes often misincorporate nucleotides when reading through RNA modifications,
such as pseudouridine and 1-methyladenosine, that are common post-transcriptional modifications
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in the 3′-end of mature tRNA [140–142]. However, known tRNA modifications do not match the
observed positions in the PBS, suggesting that these mutations are not a result of “faulty” nucleotide
incorporation during reverse transcription of the tRNA primer. Instead, they were likely acquired
through random mutagenesis and provided a fitness advantage to the ERV, resulting in the observed
high copy numbers.
Which mutations in the PBS would benefit ERVs? Fragments of the tRF3b type, both transfected
and endogenous, show all the hallmarks of miRNA silencing [22,98,101,102]. They tolerate certain
mismatches with the target, for example, Lys3-UUU tRF3b downregulates MusD6 RNA and protein
levels although it has two mismatches with its PBS [22]. For miRNA-mediated silencing, base-pairing
of the “seed” nucleotides 2–7 with the target site are highly conserved and critical [143,144]. However,
residues outside the seed are also important, for example, pairing with the 3′-end of miRNAs is a major
determinant of AGO target specificity [145]. Similarly, miRNA-reporter assays with a tRF target site
in their 3′-UTR, suggest the seed sequence is required for silencing but is not sufficient (i.e., certain
mismatches outside the seed strongly reduced silencing) [98,101]. The PBS lies 2–4 nt downstream of
the LTR in the 5′-UTR of ERVs, but it is likely that many of the rules for 3′-UTR targeting apply, both for
canonical (seed) and non-canonical base pairing. Indeed, IAP elements with mismatches to tRFs in
their PBS show higher mRNA level than IAPs with a perfect target site when released in KAP1-deficient
mESC [94]. Less is known about how tRF3a fragments find and bind their targets. tRF3aLys3-UUU did
not affect expression levels of ETn or MusD when transfected, but instead abrogated RT priming and
were highly sensitive to mismatches with the PBS irrespective of the seed sequence [22]. This suggests
that mutations in the PBS differently affect ERV expression (tRF3b) versus reverse transcription (tRF3a).
Taken together, mismatches even outside the seed region relieve repression by tRFs, both for mRNA
expression and during reverse transcription.
What else explains the pattern of mutations that we see at the PBS of these ERVs? If most
mutations reduce silencing by tRFs, the exact positions of these mutations could be driven by whether
they still allow tRNA binding and reverse transcription of the ERV. There are several lines of evidence
regarding which PBS sequences allow successful tRNA priming. A number of ERVs have been cloned
and found active in retrotransposition assays (Figure 2, right panel). Our sequence analysis reveals that
actively transposing elements of the ETn, MusD, IAPE, and IAP families tolerate 0, 2, or 3 mutations or
insertions-deletions (indels) in their PBS (Figure 2). Studies on HIV-1, which uses the same primer tRNA
as ETn and MusD, lend additional insight. The structure of the HIV-1 reverse transcription initiation
complex shows binding of the first 22 nt of the Lys3-UUU primer tRNA to the PBS [146]. However,
complementarity to the first 6 nt of the PBS has been sufficient for HIV-1 priming if compensated by
additional interactions outside the PBS [147]. A recent study examined spontaneous mutations in
HIV-1 after clustered regularly interspaced short palindromic repeat (CRISPR)-editing of the PBS [138].
Of note, HIV-1 repression is more persistent when the PBS is targeted on the minus strand because
of the asymmetrical inheritance of the PBS in Retroviridae [138]. When targeting the plus strand PBS,
the virus quickly evolves to avoid a perfect PBS. These escapees tell us which positions in the PBS
tolerate mutations during priming of reverse transcription. Remarkably, the majority of permissive
HIV-1 PBS indels are at the same positions that ETn, MusD, IAPE, and IAP have accumulated mutations
(blue shaded boxes, Figure 2), suggesting tRNA priming as well as evasion from targeting by tRFs
shape PBS sequences in ERVs.






















 14x TGGCGCCCGAACAGGGAC  ETnIIβ3, ETnIIβ1 
 24x TGGCGCCAGAACTGGGAC 
  6x TGGGGCCAGAACTGGGAC
  5x TGGCGCCTGAACAGGGAC 
  3x TGGCGCCAGCACTGGGAC  
  1x TGGCGCCCGAAGAGGGAC
  1x TGGCGCCGGAACTGGGAC  ETnIIα1
  1x TGGCACCAGAACTGGGAC
 
  3x TGGCGC-CCAACGTGGGGC 
  1x TGGCGAAACAACGTGGGAC




 65x TGGCGCCAGAACTGGGAC  MusD6
 18x TGGTGCCTGAACAGGGAC
 13x TGGCGCCTGAACAGGGAC
  7x TGGCGCCTGAACAGGGAC
  7x TGGCGCCGGAACTGGGAC  MusD1, MusD2 
  4x TGGTGCCAGAACTGGGAC
  3x TGGCGCCAGAACTGGGAA
  3x TGGCACCAGAACTGGGAC
  2x TGGTGCCTGAACAGAGAC
  2x TGGCACCCGAACAGGGAC
  2x TGGCACCTGAACAGGGAC
  2x TGGCGCCAGAACGGGGAC
  1x TGGCGCCAGAATGGGGAC
  1x TAGCGCCCGAACAGGGAC
  1x TAGTGCCAGAACTGGGAC
  1x TGGCGCCAGAACTGGGGC
  1x TGGCGCCCAACGTGGGGC
  1x TGGCGCCGGAATAGGGAC
  1x TGGCGCCTGAACTGGGAC
  1x TGGCGTCTGAACAGGGAC
  1x TGGCGTGATTA-------
  1x TGGCTCCCGAACAGGGAC
  1x TGGTGCCCGAACAGGGAC
  1x TGGTGCCTGAA-------
  1X TGGTGCCTGAATAGGGAC
  
  5x TGGTGC-CGAAACCCGGGA 
  6x TGGTGCTAGAAACCCGGGA  IAPE-D1
  5x TGGTGCT-GAAACCCGGGA
  3x TGGTGCTCGAAACCCGGGA
  1x TGGTGC-CGAAACCCGGGA
  1x TGGTGC-CGAAACTCGGGA
  1x TGGTGC-CGAAATCCGGGG
 
         
116x TGGTGCCGAAA-CCCGGGA  RP23-440N1




 10x TGGTGCTGAGA-CCCGGGA 
  8x TGGTGCCGAAAACCCGGGA  
  7x TGGTGCCGAGAACCCGGGA 
  4x TGGTGCCGAAAACCCGAGA
  4x TGGTGCCGGAAACCCGGGA
  2x TGGTGCCGAAA-CCTGGGA
  2x TGGTGCCGAAT-TCTGGGA  IAP-DJ33
  1x TGGAACGAGAAATCCTGGA
  1x TGGGACGAGAAGACCTGGA
  1x TGGGGCCGAAA-CCCGGGA
  1x TGGTGAAGAAA-TCCGGGA
  1x TGGTGCCAAAT-TCCGGGA
  1x TGGTGCCGAAA-CTCGGGA
  1x TGGTGCCGAAT-CCCGGGA
  1x TGGTGCCGAAT-TCCAGGA
  1x TGGTGCCGAAT-TCCGGGT
  1x TGGTGCCGAAT-TCCGGTA
  1x TGGTGCCGGAAACCCAGGA
  1x TGGTGCTGAAAACCCGGGA
  1x TGGTGCTGAAA-CC-GGGA
  1x TGGTGCTGGAA-CCCGGGA
  1x TGGTGGCGAAAATCCGGGA
Figure 2. Sequence variation in the 18 nucleotide tRNA primer binding site (PBS) of the
murine endogenous retroviruses (ERVs) (a) ETnIIbeta (tRNALys3), (b) ETnIIbeta (tRNALys1,2),
(c) MusD (tRNALys3), (d) IAPE (tRNAPhe), and (e) IAP (tRNAPhe). The PBS sequences with perfect
complementarity to their tRNA primer are at the top of each alignment, bold and marked with a “P”.
Numbers indicate how many full-length elements of that particular family in the mouse genome
(mm10) had a specific PBS sequence. The most common PBS sequences are denoted “C”, and PBS
sequences below are descending to less frequent variations. "Perfect" and "Common" PBS sequences
are highlighted in the phylogenetic trees in Figures S1 and S2. Mismatches with the tRNA sequence are
shaded in grey and black. Blue shaded nucleotide positions have been tolerant for mismatches when
tested for the human immunodeficiency virus (HIV)-1, which uses tRNA Lysine3 to prime reverse
transcription [138]. ERVs that were active in retrotransposition assays are denoted with their names on
the right, next to their respective PBS sequence [114,115,131].
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5. Outlook
Due to the high mutation rate of retroviruses but conservation of the PBS, several studies suggested
that destroying the PBS is the ultimate “cure” to disable LTR-retroelements [138,148]. This strategy
is promising to target infectious retroviruses like HIV in somatic tissues but would come at a high
cost in mammalian stem cells that have co-opted ERVs for cellular functions. ERV-derived lncRNAs
and LTR-driven gene-fusion transcripts could include a PBS sequence in their 5′-UTR which may
serve to fine-tune expression of these RNAs, in analogy to miRNA target sites acting as ‘rheostats’ in
the 3′-UTR of genes [149]. We would predict that PBS sequences in the 5′-UTR of LTR-driven genes
are under positive selective pressure to keep a handle on this class of developmentally regulated
genes. We believe PBS sequence variations and their prevalence in the pool of murine ERVs reflect the
tug-of-war between ERV activity and tRF-silencing. Ultimately, rules of tRF3a and tRF3b fragments
targeting the PBS in the 5′-UTR of ERVs will need to be confirmed experimentally. Many exciting
questions remain. Which tissues use 3′-tRFs as a first line of defense against infectious LTR-retroviruses?
Elevated Lys3-tRFs have been found in response to HIV-1 infection in T-cells [24]. Do 3′-tRFs regulate
LTR-retroelements in other eukaryotes? What is the intersection of the tRF silencing pathway with other
small RNA pathways? Can tRFs guide transcriptional silencing like other small RNA to re-establish
heterochromatin at transposable elements that were released by genome-wide reprogramming?
How many regulatory non-coding ERV transcripts and ERV-driven genes have retained a PBS site in
their 5′-UTR and are regulated by tRFs throughout development? Comprehensive analysis of all PBS
sites in the genome may provide insight into the genome-wide, regulatory networks that are driven by
ERV expression and their regulation by 3′-tRFs.
6. Methods
Using CENSOR and REPBASE, the following sequences were compiled (Table 1), and their
genomic coordinates were extracted from the RepeatMasker Library (20140131) of the mouse mm10
genome [150,151].
Table 1. ERV sequences used in this study to compare PBS sequences and phylogenetic relationships.
Name Genbank ID Internal LTR
ETnIIbeta3 AC126548 MMETN 1 ERVB7_1-LTR_MM
MusD6 AC124426 ERVB7_1-I_MM ERVB7_1-LTR_MM
IAPE AC123738 IAPEY4_I IAPEY4_LTR
IAP AC012382 IAPEZI IAPLTR1a_MM
1 MMETn-int is the RepeatMasker alias of MMETN in REPBASE, according to Dfam.
After reformatting to BED format, internal ERV sequences were merged to their corresponding
LTR using the BEDtools merge function within 500 bases, on the same strand [152]. Sequences less
than 500 bases were removed, and the remaining sequences were aligned with Muscle [153].
Sequences missing flanking LTRs were removed, and the frequency of each unique PBS variation was
counted across the alignment (Figure 2). The maximum likelihood trees were made using the MEGA X
program, with 500 and 300 bootstrap replicates, respectively (Figures S1 and S2) [154].
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4915/12/8/792/s1,
Figure S1: ETnIIbeta phylogenetic tree, Figure S2: MusD phylogenetic tree.
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